INS and gestational diabetes: To begin, while identifying medical conditions for research, microbiome studies must account for the pharmacological, cellular, and genetic variation of GDM women, and the pharmacogenomics profiles derived from individual treatment reactions with anti-diabetic medications or insulin prescription.